Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema

American Journal of Ophthalmology

Volumn 138, Issue 1, 2004, Pages 158-160

  Jonas, Jost B ^a,b   Degenring, Robert F ^a   Kamppeter, Bernd A ^a   Kreissig, Ingrid ^a   Akkoyun, Imren ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIFFUSE DIABETIC MACULAR EDEMA; DRUG EFFECT; DRUG SCREENING; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; PRIORITY JOURNAL; RETINA MACULA EDEMA; STATISTICAL SIGNIFICANCE; VISUAL ACUITY;

EID: 3042819546     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2004.02.025     Document Type: Article

References (5)

1. Jonas J.B., Söfker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol. 132:2001;425-427
2. Martidis A., Duker J.S., Greenberg P.B., et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology. 109:2002;920-927
3. Jonas J.B., Kreissig I., Söfker A., Degenring R.F. Intravitreal injection of triamcinolone acetonide for diabetic macular edema. Arch Ophthalmol. 121:2003;57-61
4. Danis R.P., Ciulla T.A., Pratt L.M., Anliker W. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina. 20:2000;244-250
5. Gillies M.C., Simpson J.M., Luo W., et al. A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration One-year results. Arch Ophthalmol. 121:2003;667-673